Literature DB >> 15579768

Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling.

Natalie J Hannan1, Rebecca L Jones, Hilary O D Critchley, Gabor J Kovacs, Peter A W Rogers, Biran Affandi, Lois A Salamonsen.   

Abstract

Leukocytes are critical mediators of endometrial remodeling, but the mechanisms by which leukocyte subpopulations enter the uterus are currently unknown. Endometrial leukocytes have no genomic progesterone receptors; thus, we hypothesized that leukocyte migration is induced indirectly by progesterone-regulated chemokines. Fractalkine (CX3CL1), a chemotactic membrane-bound adhesion factor, and its receptor (CX3CR1) were assessed by immunohistochemistry in endometrial samples across the menstrual cycle, in early pregnancy, and in women using progestin-only contraceptives. Fractalkine was localized predominantly to glandular epithelial and decidualized stromal cells, with the highest staining intensity in the secretory phase and early pregnancy. It was also detected in subpopulations of endometrial leukocytes (macrophages and uterine NK cells), with maximal numbers during the proliferative phase and early pregnancy. CX3CR1 was similarly colocalized to the glandular epithelium and decidualized stromal cells, with the highest expression in the secretory phase. CX3CR1-positive leukocytes (macrophages and neutrophils) were in greatest abundance during the menstrual phase. In the endometrium of women using progestin-only contraceptives, immunoreactive fractalkine was markedly reduced in the glandular epithelium, but was increased in decidualized stroma and infiltrating leukocytes. These findings support a number of roles for fractalkine in the endometrium, in the secretory phase, in early pregnancy, and when influenced by progestin-only contraceptives.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579768     DOI: 10.1210/jc.2003-031379

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Selective suppression of endothelial cytokine production by progesterone receptor.

Authors:  Lauren M Goddard; Amy N Ton; Tõnis Org; Hanna K A Mikkola; M Luisa Iruela-Arispe
Journal:  Vascul Pharmacol       Date:  2013-06-06       Impact factor: 5.773

2.  Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive.

Authors:  Sinaye Ngcapu; Lindi Masson; Sengeziwe Sibeko; Lise Werner; Lyle R McKinnon; Koleka Mlisana; Muki Shey; Natasha Samsunder; Salim Abdool Karim; Quarraisha Abdool Karim; Jo-Ann S Passmore
Journal:  J Reprod Immunol       Date:  2015-04-22       Impact factor: 4.054

3.  Uterine natural killer cell biology and role in early pregnancy establishment and outcomes.

Authors:  Jessica R Kanter; Sneha Mani; Scott M Gordon; Monica Mainigi
Journal:  F S Rev       Date:  2021-06-23

Review 4.  Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis.

Authors:  Fernando M Reis; Felice Petraglia; Robert N Taylor
Journal:  Hum Reprod Update       Date:  2013-03-28       Impact factor: 15.610

Review 5.  The role of CX3CL1 in fetal-maternal interaction during human gestation.

Authors:  Elif Kervancioglu Demirci; Lois A Salamonsen; Martin Gauster
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

Review 6.  Inflammation, leukocytes and menstruation.

Authors:  Jemma Evans; Lois A Salamonsen
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

7.  Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.

Authors:  Mark D Aupperlee; Yong Zhao; Ying Siow Tan; Jeffrey R Leipprandt; Jessica Bennett; Sandra Z Haslam; Richard C Schwartz
Journal:  Endocrinology       Date:  2014-04-02       Impact factor: 4.736

8.  Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.

Authors:  Françoise Gaudin; Salam Nasreddine; Anne-Claire Donnadieu; Dominique Emilie; Christophe Combadière; Sophie Prévot; Véronique Machelon; Karl Balabanian
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

9.  Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study.

Authors:  Alain Stepanian; Soraya Benchenni; Tiphaine Beillat-Lucas; Sophie Omnes; Fannie Defay; Edith Peynaud-Debayle; Gabriel Baron; Agnès Le Querrec; Michel Dreyfus; Laurence Salomon; Vassilis Tsatsaris; Dominique de Prost; Laurent Mandelbrot
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

10.  Defective soil for a fertile seed? Altered endometrial development is detrimental to pregnancy success.

Authors:  Jemma Evans; Natalie J Hannan; Cassandra Hincks; Luk J F Rombauts; Lois A Salamonsen
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.